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Abstract: While rearing birds in confinement and at high density are very successful practices
for producing poultry meat and eggs, these conditions may promote the spread of infectious
diseases. Consequently, the poultry industry places great emphasis on disease control measures,
primarily at the animal husbandry level. The field of genomics offers great promise to complement
these current control measures by providing information on the molecular basis for disease,
disease resistance, and vaccinal immunity. This briefly summarizes some of our efforts to apply
several genomic and functional genomics approaches to identify genes and pathways that confer
genetic resistance to Marek's disease (MD), a herpesvirus-induced T cell lymphoma of chickens.
By utilizing the "top-down" approach of QTL to identify genomics regions, and integrating it with
"bottom-up" approaches of transcript profiling and Marek's disease virus (MDV)-chicken protein-
protein interactions, three genes that confer resistance to MD are revealed, plus a number of
other positional candidate genes of high confidence. These genes can be further evaluated in
poultry breeding programmes to determine if they confer genetic resistance to MD. This integrative
genomics strategy can be applied to other infectious diseases. The impact of the genome




Poultry is the third largest agricultural commodity and the primary meat consumed
in the US and much of the world. Due to advanced breeding programmes and efficient
animal husbandry, tremendous progress in production traits has been made to meet
the growing demands ofconsumers. Several major issues confront the poultry industry
today. Infectious diseases are certainly at or near the top of the list, e.g., avian
influenza, Salmonella, and others, which harm the poultry industry through loss of
birds, reduced public confidence, and lost market accessibility via trade restrictions.
Disease outbreaks are enhanced by more concentrated chicken rearing, reduced
genetic diversity from industry consolidation, and breed uniformity to meet consumer
preferences. Changes in animal husbandry and new vaccines have alleviated some
of the problems. However, improved or alternative control measures are still needed
to address current diseases and counter emerging threats.
Genomics offers one of the more exciting avenues for addressing these issues.
The ultimate goal for genomics is to relate genetic variation at the DNA sequence
level to variation at the phenotypic level. By identifying quantitative trait loci (QTL)
and genes that control heritable traits of agricultural importance, it is possible to
select for birds with superior agricultural traits via marker-assisted selection (MAS).
Otherpositive attributes commonly cited for MAS include greater speed and accuracy
compared to traditional breeding. For infectious diseases, MAS would reduce or
eliminate the expensive and environmentally hazardous pathogen-exposure trials
needed to collect accurate disease-resistance phenotypes. The recent release of the
chicken genome sequence [1] has increased the power of genomics. This review
shows how integration of genomic and functional genomic approaches can lead to
the identification of genes and pathways that confer resistance to Marek's disease
(MD), the most serious chronic disease problem facing the poultry industry.
MAREK'S DISEASE
Marek's disease (MD) is a lymphoproliferative disease of poultry caused by
the Marek's disease virus (MDV). The pathological manifestations of MD include
immunosuppression, nerve enlargement, and lymphomas that metastasize to various
visceral organs. During the 1960s as the industry converted to high-intensity
rearing, MD generated tremendous economic losses. One of the great success
stories was the introduction of vaccines that effectively controlled MD in the
1970s. Since then, the condemnation rate attributed to MD has decreased dramatically.
However, although vaccination prevents the formation of lymphoma and other
MD symptoms, it does not prevent MDV infection, replication, or horizontal
spread. Moreover, increasingly frequent unpredictable and spontaneous vaccine
breaks due to highly virulent strains of the MDV combined with the incomplete
immunity that is elicited by vaccination [2] cause devastating damage to poultry
farms. Consequently, MD remains one of the most serious chronic infectious
disease threats to the poultry industry.
MDV is a herpesvirus that has lymphotropic properties similar to those of y-
herpesviruses, such as Epstein—Barr virus (EBV) in humans, where the host range
is restricted and latency is often evident in lymphoid tissue. Viruses of this group
are capable of transforming cells in natural hosts. MDV was re-classified, however,
because its molecular structure and genomic organization more closely resembles
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virus (VZV). The complete sequence of several MDV strains has been deterniined [2].
Genetic resistance
The best documented case for involvement of genetic resistance to MD involves
the MHC or, as it is known in the chicken, the B complex. By measuring the frequency
of specific blood groups or using B congenic chickens, it has been observed that
certain B alleles can be associated with resistance or susceptibility. The B-haplotype
also influences vaccinal immunity as some haplotypes develop better protection
with vaccines of one serotype than of a different serotype. As shown by several
studies, the B haplotype effect is dependent on genetic background. Other studies
show that genes, other than the B complex contribute to MD resistance. In particular,
in 1939, the Agricultural Research Service (ARS) laboratory in East Lansing, Ml,
initiated the development of inbred lines to study what was then known as the avian
leukosis complex. Of the fifteen lines initially developed, lines 6 and 7 proved to
be the most interesting with respect to MD. These lines share the same B2 haplotype
yet differ greatly with respect to resistance to MD. When line 6 chicks are inoculated
with the JM strain of MDV at I day of age, typically less than 5% of the chicks will
succumb to the disease. In contrast, similar inoculations into line 7 chicks will result
in greater than 90% mortality. These lines are still maintained and are over 99%
inbred. The level of disease resistance as measured by mortality among Fl siblings
of a cross between lines 6 and 7 is intermediate to that of the parents (60%), while
levels of resistance observed in the F, population derived from the above cross
encompass a wide, continuous spectrum indicating that there is more than one gene
for resistance involved. Thus, analysis of these lines and their crosses indicate that
MD resistance is a typical polygenic trait, controlled by multiple genes.
INTEGRATING GENOMICS
The presence of genetic variation in MD resistance raises the possibility of
selection for genetic resistance as a complementary control strategy to augment MD
vaccinal protection. Also, as noted above, MD resistant birds have the added advantage
that, in general, they respond better to MD vaccines. Ideally, selection for MD
resistance would be based on genetic markers within disease resistance genes or
tightly linked to them. The method is known as marker-assisted selection (MAS),
and is expected to accelerate genetic progress by increasing the accuracy of selection
and allowing for gender-independent selection at an earlier age. Furthermore, the
use of MAS for developing disease resistance avoids the necessity of challenging
breeding stock with hazardous pathogens.
With this goal in mind, we have been implementing and integrating three genomic
approaches to identify the genes that are involved in genetic variation in MD resistance:
genome wide QTL scans, gene profiling, and virus-host protein-protein interaction
screens. The rationale for using more than one approach is that the strengths of each
system can be combined to yield results of higher confidence. Another justification
is that given the large volume of data produced by genomics, each method provides
an additional screen to limit the number of targets to verify and characterize in further
experiments. The approaches are briefly described below.
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Genome-wide QTL scans
With the development of a molecular genetic map of the chicken genome [3], it
became possible through linkage mapping to identify QTLs (i.e., chromosomal
regions containing genes or other genomic elements) controlling complex traits,
including disease resistance. Our efforts have utilized resource populations based
on experimental inbred lines [4,5] and commercial strains [6]. The use of the
experimental lines allows for more precisely controlled environmental conditions
and trait measurements while the use of commercial strains is more agriculturally
relevant and permits many more birds to be produced and evaluated. In all populations,
many QTLs of small to moderate effect were identified, which agrees well with
earlier conclusions as to the multigenic nature of MD resistance. Some ofthe identified
QTL locations are common across experimental and commercial populations,
providing additional confidence in these QTLs and suggests that results from
experimental populations can be transferred to commercial lines [6]. It should be
noted, however, that all experiments to date have been implemented in White Leghorn
lines, which have a known narrow genetic base and consequently, a high degree of
interrelatedness. It is not known to what extent these QTLs are also responsible for
genetic variation in MD resistance in broiler lines.
Genome-wide scans for QTLs conferring MD resistance have been conducted on
crosses between ADOL lines 6 (MD resistant) and 7 (MD susceptible). Specifically,
in a 6 x 7 F2 population genotyped with 127 genetic markers, 14 QTLs (7 significant
and 7 suggestive) were identified that explain one or more MD-associated trait. The
QTL5 were of small to moderate effect explaining 2 to 10% of the phenotypic variance,
with standardized additive gene substitution effects from 0.01 to 1.05 phenotypic
standard deviations. Collectively, the QTLs explained up to 75% ofthe genetic variance.
Interestingly, 10 of the 14 QTLs displayed non-additive gene action: 3 were over-
dominant and 7 were recessive. Theoretically, MAS would be useful in exploiting
non-additive QTLs. Three ofthe QTLs were associated almost exclusively with viremia
levels while the remaining QTL5 could account fordisease incidence, survival, tumours,
nerve enlargement, and other disease associated traits. This suggests that disease
resistance occurs at least at two levels: initial viral replication and cellular transformation,
which occurs later. It also highlights the added value of measuring several components
as this may functionally separate a complex trait into more highly heritable physiological
components, as well as provide clues for identifying positional candidate genes.
More recently, with the advent ofthe genome sequence, millions ofhigh-confidence
SNPs [7], and high-throughput genotyping systems, it became possible to genotype
large resource populations very quickly and economically. Using the Illumina platform,
we were able to re-evaluate the 6 x 7 F2 MD line resource population with 578 additional
genetic markers [8]. Most interestingly, partly due to the higher accuracy of calling
genotypes with SNPs, a search for two-locus epistatic interactions was conducted. A
large number of highly significant two-way interactions were found that could account
for viremia; no highly significant interactions were revealed for MD or survival. A
total of 239 highly marker-to-marker significant interactions (LRS >57.8; genome-
wide P <0.001) were identified [8]. The location of loci and their interacting partners
appears to be distributed throughout the genome. On the other hand, loci in specific
regions on chromosomes 1 and 4 are frequently involved; a single region on chromosome
I accounted for 166 of the 239 highly significant interactions. Interestingly, most if
not all of the interacting loci are not in the QTL regions previously identified.
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These results imply that (1) interactions between loci can make a substantial
contribution to variation in complex traits, (2) because of the growing awareness of
biological complexity, genome-wide QTL scans should attempt to incorporate
resource populations for which the genotyping and analytical capabilities available
today or in the near future can be used, and (3) the challenge remains to identify the
underlying genes and genetic variation for QTL as the confidence intervals are fairly
large and encompass many genes.
Gene profiling
The population sizes and structures that have been used for mapping QTLs
affecting MD resistance can only map the causative gene or genetic element to rather
broad chromosomal regions extending for tens ofcentimorgans and containing many
hundreds of genes. For this reason, it is clear that it will be extremely difficult to
identify positional candidate genes for MD resistance using approaches based on
general functional annotation and positional genetics only. Gene expression profiling
using microarray hybridization technology is a powerful tool for gene function
studies. Our hope is that DNA microarrays will identify genes and pathways specifically
involved in MD resistance, which combined with linkage mapping and functional
annotation of the genome can narrow the field of positional candidate genes [ 9 ] . In
other words, positional candidate genes are those that have a genetic association,
are functionally relevant, and are identified as being relevant to MD resistance
through gene expression analyses.
Gene profiling has been conducted to identify differentially expressed genes
between lines 6 and 7 after MDV challenge [9] among B (MHC) congenic lines of
chickens following inoculation with different MD vaccines, and in chicken embryo
fibroblasts (CEF) infected with MDV. Analyses of these experiments have identified
a number of genes and pathways that are consistently associated with either MD
resistance or MDV infection. Remarkably, the results suggest that chickens with
immune systems that are more stimulated by MDV infection are more susceptible.
Initially, this seems counterintuitive but upon further reflection, MDV is thought to
only infect activated lymphocytes. Thus, chickens with immune systems that are
more responsive may present more targets for MDV to infect and later transform.
Although DNA microarray experiments can be very powerful and the results
enlightening, our experiences also suggest that it is critical to study the response of
cells in a limited or local environment. For example, MHC class I expression was
increased in MDV-infected CEF [101. However, upon closer examination ofindividual
cells, virus-infected cells actually expressed reduced levels of MHC on their cell
surfaces but neighbouring uninfected cells had elevated levels of MHC class I. To
partially circumvent the problem ofheterogeneous response ofindividual components
of samples, laser capture microdissection (LCM) and cell sorting has been used to
isolate the cells of interest.
Virus-host protein-protein interaction screens
The third component of this approach to identifying the genes associated with
MD resistance is to systematically examine protein interactions associated with MD
resistance. Specifically, a two-hybrid screen has been used to detect MDV-chicken
protein-protein interactions. Our hypothesis was that some chicken proteins that
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interact with MDV proteins are involved in the immune response and genetic resistance
to MD. Thus, the two-hybrid system could be used to quickly identify interacting
proteins which, when combined with genetic mapping, would identify positional
candidate genes for MD resistance.
The MDV SORF2 gene was initially chosen as bait due to its potential role in
the attenuation of the MDV RM1 strain [11]. Using the yeast two-hybrid system
and a splenic cDNA library, growth hormone (GH) was found to specifically interact
with SORF2 [11]. To corroborate the detected interaction, an in vitro protein binding
assay using GST-fusion proteins was performed to confirm direct binding of GH to
SORF2. The results show that, while SORF2 protein was not retained by GST protein
alone, SORF2 can be retained by GST-GH fusion protein, presumably due to the
presence of GH. This result is in agreement with the result of the yeast two-hybrid
system assay and indicates that the interaction between SORF2 and GH is a direct
and specific protein-protein interaction.
Based on these results, the GH gene (GHI) was treated as a candidate gene for MD
resistance. To determine if GH] contributed to the genetic basis of MD resistance, an
association study involving an SN P in GH I was conducted in an MD resource population
derived from commercial White Leghorn lines. Indeed, it was found that GHJ allelic
variation was significantly associated (P <0.01) with a number of MD-associated traits
in MHC B2/B' 5 chicks [11]. Furthermore, providing functional information support,
DNA microarray results indicate that GH is differentially expressed between MD
resistant (line 6) and susceptible (line 7) chicks after MDV challenge [9].
Thus, the combined results of a specific MDV-chicken protein interaction,
differential expression of GH between MD resistant and susceptible chickens, and
association of GHJ allelic variation with MD-related traits and selected lines for
MD resistance, all strongly suggest that GHJ is a MD resistance gene. This conclusion
is supported by reports demonstrating that GH modulates the immune system in
many species, and frequency of GHI alleles differs in the expected direction in
chicken strains in response to selection for MD resistance. Most importantly, it
exemplifies the power of combining genetic and molecular approaches to identify
positional candidate genes for QTL.
With the complete sequence of the MDV genome, it became feasible to conduct
a systematic screen of the relevant MDV genes for interacting chicken partners. All
the MDV genes that are considered unique to serotype I (virulent) strains were
screened, and all potential MDV-host protein interactions were tested by an in vitro
binding assay to confirm the initial two-hybrid results. As a result, 8 new MDV-
chicken protein interactions were identified[ 12]. More importantly, genetic mapping
and association analyses ofthe encoding chicken genes revealed that L Y6E [lymphocyte
complex 6, locus E; also known as stem cell antigen 2 (SCA2) and thymic shared
antigen 1 (TSAJ)] is another MD resistance gene [13] and further suggest that BLB,
the gene for MHC class 1113 chain, is a strong positional candidate gene 12].
Higher order protein-protein interactions can be revealed with gentle cell lysis
and immunoprecipitation of a protein complex using antibodies directed against one
member of the complex. The identity of the other interacting proteins can be quickly
revealed through mass spectrometry, which is now facilitated by the availability of
the whole genome sequence. To extend the MD V-chicken protein interactions, we
are employing tandem affinity purification (TAP) tag to several chicken-MDV protein
complexes. Rather than expressing the viral gene product alone, we plan to take
advantac oour infcctiou \11)\ Br\C ctonc [14] and the ability to make defined
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recombinant viruses. The use of these viruses expressing TAP-tagged MDV proteins
during infection allows for the use of a system closer to normal viral infection, which
will hopefully yield useful information on the biology of viral infection and the role
of host-virus interactions in that context.
CONCLUSION
It has been over 30 years since MDV was identified as the causative agent of
MD, and effective vaccines produced. In spite of our ability to detect and protect
against MD, there is a surprising lack of information on the components of the
chicken immune system that confer disease resistance and contribute to vaccinal
immunity. With the advent ofnew technologies, we believe that our ability to tangibly
improve upon MD control mechanisms is at hand. The key to making rapid gains
will be the ability to integrate various methods and information. If this occurs, then
we should be able to accelerate the transition from serendipity to rational, mechanism-
based control of disease and food production in the poultry industry.
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